VEGFA and age-related macular degeneration: Additionally, an early phase I study (NCT05099094) is evaluating BD311 (Shanghai BDgene Co., Ltd.), an integration-deficient lentiviral vector (IDLV)-expressing VEGFA antibody effective in exudative AMD in a murine model [172].